These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10875033)

  • 21. Evaluation of nitrate tolerance in patients with coronary heart disease by vascular ultrasonography and treadmill exercise.
    Yu GL; Zhuang HP; Wang ZH; Liao JT
    Int J Cardiol; 1999 May; 69(2):133-7. PubMed ID: 10549836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The poststenotic vessel segment during dynamic exercise: effect of oral isosorbide-dinitrate.
    Gaglione A; Hess OM; Haemmerli C; Suter T; Kirkeeide RL; Osenberg HP; Muser M; Anliker M; Gould KL; Krayenbuehl HP
    Basic Res Cardiol; 1990; 85 Suppl 1():347-57. PubMed ID: 2091610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nisoldipine versus isosorbide dinitrate in coronary heart disease: results of a double-masked study.
    Heublein B; Amende I; Blanke PM; Baunack-Frost AR; Breuer HW
    Clin Ther; 1996; 18(3):448-59. PubMed ID: 8829020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous long-term dosing with oral slow-release isosorbide dinitrate does not reduce incidence of cardiac events in patients with healed myocardial infarction.
    Kanamasa K; Hayashi T; Takenaka T; Kimura A; Ikeda A; Ishikawa K;
    Clin Cardiol; 2001 Sep; 24(9):608-14. PubMed ID: 11558843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
    Fung HL
    Am Heart J; 1985 Jul; 110(1 Pt 2):213-6. PubMed ID: 4013997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamics and coronary dynamics under ISDN long-term therapy].
    Wortmann A; Bachmann K; Deuber HJ; Roth E
    Z Kardiol; 1986; 75 Suppl 3():68-76. PubMed ID: 3798997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
    Schartl M; Dougherty C; Rutsch W; Schmutzler H
    Am Heart J; 1985 Mar; 109(3 Pt 2):649-53. PubMed ID: 3838401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma volume expansion may explain the attenuation of antianginal activity of oral isosorbide dinitrate in long-term therapy].
    Kośmicki M; Sadowski Z
    Pol Arch Med Wewn; 1999 Nov; 102(5):967-72. PubMed ID: 11072531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic study of the development of tolerance in intravenous nitrate therapy].
    Unverdorben M; Pfeiffer F; Kunkel B; Bachmann K
    Z Kardiol; 1989; 78 Suppl 2():88-94; discussion 115-7. PubMed ID: 2686259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
    Dalal JJ; Parker JO
    Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug plasma levels and coronary vasodilation after isosorbide dinitrate chewing capsules.
    Jost S; Rafflenbeul W; Knop I; Bossaller C; Gulba D; Hecker H; Lippolt P; Lichtlen PR
    Eur Heart J; 1989 Nov; 10 Suppl F():137-41. PubMed ID: 2620680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
    Lehmann G; Reiniger G; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):25-30. PubMed ID: 9456273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance to isosorbide dinitrate: rate of development and reversal.
    Parker JO; Fung HL; Ruggirello D; Stone JA
    Circulation; 1983 Nov; 68(5):1074-80. PubMed ID: 6616789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the therapeutic efficacy of continuous and intermittent injection of isosorbide dinitrate: a randomized study on unstable angina.
    Miyazaki S; Nonogi H; Goto Y; Sumiyoshi T; Haze K; Hiramori K
    Intern Med; 1995 Sep; 34(9):856-62. PubMed ID: 8580556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina.
    Toyosaki N; Katsuki T; Fujii M; Kawada Y; Komaba A; Watabiki H; Hasegawa H; Suzuki S; Natsume T; Yaginuma T
    Jpn Circ J; 1989 May; 53(5):395-405. PubMed ID: 2769927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of nitrate tolerance and usefulness of pulse therapy in a patient with vasospastic angina.
    Hoshio A; Shirota K; Sawada Y; Doi T; Miyakoda H; Kotake H; Mashiba H
    Eur Heart J; 1992 Jun; 13(6):853-5. PubMed ID: 1623880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.